Papaioannou A et al (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. Can Med Assoc J 182(17):1864
Watts NB et al (2012) Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97(6):1802–1822
Article CAS PubMed Google Scholar
Conley RB et al (2020) Secondary fracture prevention: consensus clinical recommendations from a multistakeholder coalition. J Bone Miner Res 35(1):36–52
Camacho PM et al (2016) American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis - 2016--Executive Summary. Endocr Pract 22(9):1111–1118
MacLean C et al (2008) Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 148(3):197–213
Cranney A et al (2002) Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23(4):570–578
Article CAS PubMed Google Scholar
Lyles KW et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799–1809
Article CAS PubMed Google Scholar
Cummings SR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361(8):756–765
Article CAS PubMed Google Scholar
Bolland MJ et al (2010) Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrinol Metabol 95(3):1174–1181
Giangregorio L et al (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35(5):293–305
Article CAS PubMed Google Scholar
Public Health Agency of Canada (2020) Osteoporosis and related fractures in Canada: report from the Canadian Chronic Disease Surveillance System 2020. Public Health Agency of Canada
Ansari H et al (2023) Characterization of hip fractures among adults with schizophrenia in Ontario, Canada. JAMA Netw Open 6(4):e2310550–e2310550
Article PubMed PubMed Central Google Scholar
Stubbs B et al (2015) Schizophrenia and the risk of fractures: a systematic review and comparative meta-analysis. Gen Hosp Psychiatry 37(2):126–133
Kelly DL et al (2011) The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders. Osteoporos Int 22(4):1133–1143
Article CAS PubMed Google Scholar
Bishop JR et al (2004) Osteoporosis screening and treatment in women with schizophrenia: a controlled study. Pharmacother: The J Human Pharmacol Drug Ther 24(4):515–521
De Hert M et al (2011) Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatr 10(2):138–151
De Hert M et al (2011) Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatr: official J World Psychiatr Association (WPA) 10(1):52–77
Firth J et al (2019) The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatr 6(8):675–712
Haentjens P et al (2010) Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men. Ann Intern Med 152(6):380–390
Article PubMed PubMed Central Google Scholar
Braveman P, Gruskin S (2003) defining equity in health. J Epidemiol Community Health 57(4):254–258
Article CAS PubMed PubMed Central Google Scholar
Kurdyak P et al (2015) Validation of a population-based algorithm to detect chronic psychotic illness. Canadian journal of psychiatry. Revue canadienne de psychiatrie 60(8):362–368
PubMed PubMed Central Google Scholar
Sampsel S et al (2007) Methods to develop arthritis and osteoporosis measures: a view from the National Committee for Quality Assurance (NCQA). Clin Exp Rheumatol 25(6):S22
NCQA. Measuring Quality. Improving healthcare. HEDIS Measures and Technical Resources; Available from: https://www.ncqa.org/hedis/measures/.
Jaglal S et al (2020) Ontario Osteoporosis Strategy - Provincial Performance Data for Osteoporosis Management Technical Report. Ontario Osteoporosis Strategy
Cadarette SM et al (2011) Osteoporosis quality indicators using healthcare utilization data. Osteoporos Int 22(5):1335–1342
Article CAS PubMed Google Scholar
Kralj B (2009) Measuring Rurality - RIO2008_BASIC: methodology and results, Toronto
Austin PC, Newman A, Kurdyak PA (2012) Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a population-based cohort of adults with schizophrenia in Ontario, Canada. Psychiatry Res 196(1):32–37
McIsaac DI et al (2016) The impact of frailty on outcomes and healthcare resource usage after total joint arthroplasty. The Bone & Joint J 98-B(6):799–805
McIsaac DI, Bryson GL, van Walraven C (2016) Association of frailty and 1-year postoperative mortality following major elective noncardiac surgery: a population-based Cohort Study. JAMA Surg 151(6):538–545
Tran DTT et al (2018) Association of frailty and long-term survival in patients undergoing coronary artery bypass grafting. J Am Heart Assoc 7(15):e009882
Article PubMed PubMed Central Google Scholar
Sternberg SA et al (2012) Identifying frail older people using predictive modeling. Am J Manag Care 18(10):e392–e397
Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94(446):496–509
Lau B, Cole SR, Gange SJ (2009) Competing risk regression models for epidemiologic data. Am J Epidemiol 170(2):244–256
Article PubMed PubMed Central Google Scholar
Zhou B, Fine J, Laird G (2013) Goodness-of-fit test for proportional subdistribution hazards model. Stat Med 32(22):3804–3811
Austin PC, Fine JP (2017) Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med 36(27):4391–4400
Article PubMed PubMed Central Google Scholar
Aday LA, Andersen R (1974) A framework for the study of access to medical care. Health Serv Res 9(3):208–220
CAS PubMed PubMed Central Google Scholar
Cadarette SM et al (2007) Access to osteoporosis treatment is critically linked to access to dual-energy x-ray absorptiometry testing. Med Care 45(9):896–901
Cadarette SM, Jaglal SB, Hawker GA (2005) Fracture prevalence and treatment with bone-sparing agents: are there urban-rural differences? A population based study in Ontario. Canada J Rheumatol 32(3):550–558
Bliuc D et al (2023) The association between multimorbidity and osteoporosis investigation and treatment in high-risk fracture patients in Australia: a prospective cohort study. PLoS Med 20(1):e1004142
Article PubMed PubMed Central Google Scholar
Gillespie CW, Morin PE (2017) Osteoporosis-related health services utilization following first hip fracture among a cohort of privately-insured women in the United States, 2008–2014: An Observational Study. J Bone Miner Res 32(5):1052–1061
Khosla S et al (2017) Addressing the crisis in the treatment of osteoporosis: a path forward. J Bone Miner Res 32(3):424–430
Roux C, Briot K (2020) The crisis of inadequate treatment in osteoporosis. The Lancet Rheumatol 2(2):e110–e119
Beaton DE et al (2017) Improvements in osteoporosis testing and care are found following the wide scale implementation of the Ontario Fracture Clinic Screening Program: an interrupted time series analysis. Medicine 96(48):e9012–e9012
Article PubMed PubMed Central Google Scholar
Ganda K et al (2013) Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int 24(2):393–406
Article CAS PubMed Google Scholar
Ansari H et al (2017) Equal treatment: no evidence of gender inequity in osteoporosis management in a coordinator-based fragility fracture screening program. Osteoporos Int 28(12):3401–3406
留言 (0)